Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?
Highlights ► All lyssaviruses can cause fatal encephalitic disease. ► Rabies vaccines protect against phylogroup I lyssaviruses but not against phylogroup II viruses. ► Here we review lyssavirus vaccinology and focus on the antigenicity of the glycoprotein. ► The discovery of divergent lyssaviruses...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2012-12, Vol.30 (52), p.7447-7454 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7454 |
|---|---|
| container_issue | 52 |
| container_start_page | 7447 |
| container_title | Vaccine |
| container_volume | 30 |
| creator | Evans, Jennifer S Horton, Daniel L Easton, Andrew J Fooks, Anthony R Banyard, Ashley C |
| description | Highlights ► All lyssaviruses can cause fatal encephalitic disease. ► Rabies vaccines protect against phylogroup I lyssaviruses but not against phylogroup II viruses. ► Here we review lyssavirus vaccinology and focus on the antigenicity of the glycoprotein. ► The discovery of divergent lyssaviruses suggests a need for novel pan-lyssavirus vaccines. |
| doi_str_mv | 10.1016/j.vaccine.2012.10.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1348487242</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X12014612</els_id><sourcerecordid>1348487242</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-461a74e83217521325c8af0df937b5e85fa24ebe2ad33b114290b0792e7713133</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxS0EotvCRwAicekli2dsxw4HKlT-VaqERKnEzXKcCXjJJou9WWm_PY52AdFLL7Y1-s2T37xh7BnwJXCoXq2WO-d9GGiJHDDXlhzUA7YAo0WJCsxDtuBYyVIC_3bCTlNacc6VgPoxO0HBjTRKLti7L64JlIpdiFM-D5LpdXGViu0PilS4YiBqi26M-blxQ9nvU3L_4RdP2KPO9YmeHu8zdvvh_dfLT-X1549Xl2-vS6-42payAqclGYGgFYJA5Y3reNvVQjeKjOocSmoIXStEAyCx5g3XNZLWIECIM3Z-0N3E8ddEaWvXIXnqezfQOCULQmZbGiXejyKCUcLoOqMv76CrcYpDNmKhQmUMVLXJlDpQPo4pRersJoa1i3sL3M6J2JU9zsPOiczlnEjue35Un5o1tX-7_kSQgRcHoHOjdd9jSPb2JisozkEbwatMXBwIyrPdBYo2-UCDpzZE8lvbjuHeT7y5o-D7MATv-p-0p_TPr01oub2ZF2feG8giOTUUvwFIALk5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625881698</pqid></control><display><type>article</type><title>Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Evans, Jennifer S ; Horton, Daniel L ; Easton, Andrew J ; Fooks, Anthony R ; Banyard, Ashley C</creator><creatorcontrib>Evans, Jennifer S ; Horton, Daniel L ; Easton, Andrew J ; Fooks, Anthony R ; Banyard, Ashley C</creatorcontrib><description>Highlights ► All lyssaviruses can cause fatal encephalitic disease. ► Rabies vaccines protect against phylogroup I lyssaviruses but not against phylogroup II viruses. ► Here we review lyssavirus vaccinology and focus on the antigenicity of the glycoprotein. ► The discovery of divergent lyssaviruses suggests a need for novel pan-lyssavirus vaccines.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2012.10.015</identifier><identifier>PMID: 23084854</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Animals ; antigenic variation ; Bats ; death ; Fatalities ; Genetic Variation ; Glycoprotein ; glycoproteins ; Humans ; Lyssavirus ; Lyssaviruses ; pathogens ; Protection ; Rabies ; Rabies - prevention & control ; Rabies - veterinary ; Rabies - virology ; Rabies Vaccines - immunology ; Rabies virus ; Rabies virus - classification ; Rabies virus - genetics ; Rabies virus - immunology ; risk ; Vaccines ; viruses</subject><ispartof>Vaccine, 2012-12, Vol.30 (52), p.7447-7454</ispartof><rights>2012</rights><rights>Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 14, 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-461a74e83217521325c8af0df937b5e85fa24ebe2ad33b114290b0792e7713133</citedby><cites>FETCH-LOGICAL-c505t-461a74e83217521325c8af0df937b5e85fa24ebe2ad33b114290b0792e7713133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1625881698?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23084854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evans, Jennifer S</creatorcontrib><creatorcontrib>Horton, Daniel L</creatorcontrib><creatorcontrib>Easton, Andrew J</creatorcontrib><creatorcontrib>Fooks, Anthony R</creatorcontrib><creatorcontrib>Banyard, Ashley C</creatorcontrib><title>Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights ► All lyssaviruses can cause fatal encephalitic disease. ► Rabies vaccines protect against phylogroup I lyssaviruses but not against phylogroup II viruses. ► Here we review lyssavirus vaccinology and focus on the antigenicity of the glycoprotein. ► The discovery of divergent lyssaviruses suggests a need for novel pan-lyssavirus vaccines.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>antigenic variation</subject><subject>Bats</subject><subject>death</subject><subject>Fatalities</subject><subject>Genetic Variation</subject><subject>Glycoprotein</subject><subject>glycoproteins</subject><subject>Humans</subject><subject>Lyssavirus</subject><subject>Lyssaviruses</subject><subject>pathogens</subject><subject>Protection</subject><subject>Rabies</subject><subject>Rabies - prevention & control</subject><subject>Rabies - veterinary</subject><subject>Rabies - virology</subject><subject>Rabies Vaccines - immunology</subject><subject>Rabies virus</subject><subject>Rabies virus - classification</subject><subject>Rabies virus - genetics</subject><subject>Rabies virus - immunology</subject><subject>risk</subject><subject>Vaccines</subject><subject>viruses</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk9v1DAQxS0EotvCRwAicekli2dsxw4HKlT-VaqERKnEzXKcCXjJJou9WWm_PY52AdFLL7Y1-s2T37xh7BnwJXCoXq2WO-d9GGiJHDDXlhzUA7YAo0WJCsxDtuBYyVIC_3bCTlNacc6VgPoxO0HBjTRKLti7L64JlIpdiFM-D5LpdXGViu0PilS4YiBqi26M-blxQ9nvU3L_4RdP2KPO9YmeHu8zdvvh_dfLT-X1549Xl2-vS6-42payAqclGYGgFYJA5Y3reNvVQjeKjOocSmoIXStEAyCx5g3XNZLWIECIM3Z-0N3E8ddEaWvXIXnqezfQOCULQmZbGiXejyKCUcLoOqMv76CrcYpDNmKhQmUMVLXJlDpQPo4pRersJoa1i3sL3M6J2JU9zsPOiczlnEjue35Un5o1tX-7_kSQgRcHoHOjdd9jSPb2JisozkEbwatMXBwIyrPdBYo2-UCDpzZE8lvbjuHeT7y5o-D7MATv-p-0p_TPr01oub2ZF2feG8giOTUUvwFIALk5</recordid><startdate>20121214</startdate><enddate>20121214</enddate><creator>Evans, Jennifer S</creator><creator>Horton, Daniel L</creator><creator>Easton, Andrew J</creator><creator>Fooks, Anthony R</creator><creator>Banyard, Ashley C</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U2</scope></search><sort><creationdate>20121214</creationdate><title>Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?</title><author>Evans, Jennifer S ; Horton, Daniel L ; Easton, Andrew J ; Fooks, Anthony R ; Banyard, Ashley C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-461a74e83217521325c8af0df937b5e85fa24ebe2ad33b114290b0792e7713133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>antigenic variation</topic><topic>Bats</topic><topic>death</topic><topic>Fatalities</topic><topic>Genetic Variation</topic><topic>Glycoprotein</topic><topic>glycoproteins</topic><topic>Humans</topic><topic>Lyssavirus</topic><topic>Lyssaviruses</topic><topic>pathogens</topic><topic>Protection</topic><topic>Rabies</topic><topic>Rabies - prevention & control</topic><topic>Rabies - veterinary</topic><topic>Rabies - virology</topic><topic>Rabies Vaccines - immunology</topic><topic>Rabies virus</topic><topic>Rabies virus - classification</topic><topic>Rabies virus - genetics</topic><topic>Rabies virus - immunology</topic><topic>risk</topic><topic>Vaccines</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evans, Jennifer S</creatorcontrib><creatorcontrib>Horton, Daniel L</creatorcontrib><creatorcontrib>Easton, Andrew J</creatorcontrib><creatorcontrib>Fooks, Anthony R</creatorcontrib><creatorcontrib>Banyard, Ashley C</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Safety Science and Risk</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evans, Jennifer S</au><au>Horton, Daniel L</au><au>Easton, Andrew J</au><au>Fooks, Anthony R</au><au>Banyard, Ashley C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2012-12-14</date><risdate>2012</risdate><volume>30</volume><issue>52</issue><spage>7447</spage><epage>7454</epage><pages>7447-7454</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights ► All lyssaviruses can cause fatal encephalitic disease. ► Rabies vaccines protect against phylogroup I lyssaviruses but not against phylogroup II viruses. ► Here we review lyssavirus vaccinology and focus on the antigenicity of the glycoprotein. ► The discovery of divergent lyssaviruses suggests a need for novel pan-lyssavirus vaccines.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>23084854</pmid><doi>10.1016/j.vaccine.2012.10.015</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2012-12, Vol.30 (52), p.7447-7454 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1348487242 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Allergy and Immunology Animals antigenic variation Bats death Fatalities Genetic Variation Glycoprotein glycoproteins Humans Lyssavirus Lyssaviruses pathogens Protection Rabies Rabies - prevention & control Rabies - veterinary Rabies - virology Rabies Vaccines - immunology Rabies virus Rabies virus - classification Rabies virus - genetics Rabies virus - immunology risk Vaccines viruses |
| title | Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T06%3A18%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rabies%20virus%20vaccines:%20Is%20there%20a%20need%20for%20a%20pan-lyssavirus%20vaccine?&rft.jtitle=Vaccine&rft.au=Evans,%20Jennifer%20S&rft.date=2012-12-14&rft.volume=30&rft.issue=52&rft.spage=7447&rft.epage=7454&rft.pages=7447-7454&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2012.10.015&rft_dat=%3Cproquest_cross%3E1348487242%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1625881698&rft_id=info:pmid/23084854&rft_els_id=S0264410X12014612&rfr_iscdi=true |